CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-28 | Wise John Drayton Chief Commercial Officer | Exercise or conversion 10b5-1 | +6,250 | $12.58 | $79K | 127,907 |
| 2024-05-28 | Wise John Drayton Chief Commercial Officer | Sale 10b5-1 | −6,250 | $50.00 | $313K | 121,657 |
| 2024-05-28 | Wise John Drayton Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,250 | 0 | ||
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion 10b5-1 | +7,000 | $16.07 | $112K | 101,579 |
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion 10b5-1 | +10,000 | $16.16 | $162K | 111,579 |
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion 10b5-1 | +3,691 | $10.85 | $40K | 115,270 |
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion 10b5-1 | +3,470 | $11.38 | $39K | 118,740 |
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion 10b5-1 | +14,810 | $13.67 | $202K | 133,550 |
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −44,722 | $49.53 | $2.2M | 88,828 |
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −7,000 | 0 | ||
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −10,000 | 0 | ||
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,691 | 0 | ||
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,470 | 0 | ||
| 2024-05-28 | Smith Michael Alexander Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −14,810 | 0 | ||
| 2024-05-28 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion 10b5-1 | +27,500 | $12.58 | $346K | 136,260 |
| 2024-05-28 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −27,500 | $49.53 | $1.4M | 108,760 |
| 2024-05-28 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −27,500 | 0 | ||
| 2024-05-28 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion 10b5-1 | +103,806 | $23.66 | $2.5M | 209,940 |
| 2024-05-28 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −103,806 | $49.62 | $5.2M | 106,134 |
| 2024-05-28 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −103,806 | 18,874 |
Page 39 of 42 · 826 trades